Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H1419

Introduced
2/27/25  

Caption

Relative to pharmacy deserts

Impact

If enacted, H1419 seeks to understand the implications of pharmacy deserts on healthcare access and outcomes for residents, particularly those living in underserved neighborhoods. The findings from this assessment will provide valuable insights into how pharmacy deserts affect access to medications, healthcare costs, and overall health disparities in the state. Furthermore, it emphasizes the need for policy recommendations that can alleviate these barriers and improve healthcare services in affected areas.

Summary

House Bill H1419 aims to address the issue of pharmacy deserts in the Commonwealth of Massachusetts by requiring the Office of Health Resource Planning to conduct a thorough assessment of the state's pharmacy services. This assessment will identify existing and potential pharmacy deserts – areas with limited access to pharmacies due to geographical and transportation factors. The bill defines a pharmacy desert and sets criteria for what qualifies as such, focusing on metrics like distance to the nearest pharmacy and travel time by various means of transportation.

Contention

Notably, the bill addresses significant concerns surrounding healthcare equity, as it seeks to ensure that all residents, regardless of location, have consistent access to essential pharmacy services. The identification of pharmacy deserts could bring to light the geographic and financial barriers faced by many individuals, allowing for targeted interventions. Critics may argue about potential resistance from pharmacy benefit managers or businesses that could oppose regulatory changes aimed at improving access. Such discussions may evolve as the bill progresses, highlighting the multifaceted challenges in regulating healthcare accessibility.

Companion Bills

No companion bills found.

Previously Filed As

MA S2520

Relative to pharmaceutical access, costs and transparency

MA S2499

Relative to pharmaceutical access, costs and transparency

MA S749

Relative to pharmaceutical access, costs and transparency

MA S2492

Relative to pharmaceutical access, costs and transparency

MA S732

Relative to promoting comprehensive transparency in the pharmaceutical industry

MA H1176

Relative to promoting comprehensive transparency in the pharmaceutical industry

MA S3012

Relative to pharmaceutical access, costs and transparency

MA H4910

Similar Bills

MA S783

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA H1215

Relative to pharmacy benefit managers

Similar Bills

CA AB913

Pharmacy benefit managers.

CA SB362

Chain community pharmacies: quotas.

LA HB432

Provides for the regulation of pharmacy services administrative organizations (OR +$88,000 SG EX See Note)

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

LA HB387

Provides for the regulation of pharmacy services administrative organizations

CA AB401

Pharmacy: remote dispensing site pharmacy: telepharmacy: shared clinic office space.

CA AB690

Pharmacies: relocation: remote dispensing site pharmacy: pharmacy technician: qualifications.

MS HB1119

Pharmacy benefit managers; revise provisions related to.